Tumor-Associated CD68(+), CD163(+), and MARCO(+) Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma

Background: Despite improvements in surgical methodologies and perioperative chemo- and radiotherapy, the prognosis for patients with esophageal and gastric cancer remains poor. Hence, there is a great need to identify complementary biomarkers for improved treatment stratification. Tumor-infiltratin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeremiasen, Martin, Borg, David, Hedner, Charlotta, Svensson, Maria, Nodin, Björn, Leandersson, Karin, Johansson, Jan, Jirström, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645217/
https://www.ncbi.nlm.nih.gov/pubmed/33194593
http://dx.doi.org/10.3389/fonc.2020.534761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645217/
https://www.ncbi.nlm.nih.gov/pubmed/33194593
http://dx.doi.org/10.3389/fonc.2020.534761

Ejemplares similares